Stay updated on TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.

Latest updates to the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe page now displays a recruitment-status note ('No longer looking for participants') and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The label for the section 'Intervention / Treatment' was changed to 'Intervention/Treatment', and the revision line updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check13 days agoChange DetectedA new page revision entry, v3.5.5, was added and the previous v3.5.4 entry removed, updating the page's revision history to reflect the latest version.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page's revision label updated from Revision: v3.5.3 to Revision: v3.5.4, reflecting a new version of the ClinicalTrials.gov record.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3. This indicates a small update to the study record metadata.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.5.2 has been added and v3.5.0 removed, indicating a minor version patch to the site.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.